## Abstract Recent years have seen the release of multiple new systemic antifungal agents, significantly increasing options for the treatment of most serious fungal infections. Newly available drugs include those in the echinocandin class, including caspofungin, micafungin, and anidulafungin, as we
โฆ LIBER โฆ
Newer antifungal agents
โ Scribed by Walid Abuhammour; Eyassu Habte-Gaber
- Book ID
- 110654504
- Publisher
- Springer-Verlag
- Year
- 2004
- Tongue
- English
- Weight
- 695 KB
- Volume
- 71
- Category
- Article
- ISSN
- 0019-5456
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Clinical indications for newer antifunga
โ
Nina Naeger-Murphy; James C. Pile
๐
Article
๐
2009
๐
John Wiley and Sons
๐
English
โ 118 KB
Drug interactions of the newer oral anti
โ
Katz
๐
Article
๐
1999
๐
John Wiley and Sons
๐
English
โ 111 KB
The newer oral antifungal agents, such as fluconazole, itraconazole and terbinafine, are generally both effective and well tolerated in the management of widespread or resistant dermatomycoses such as onychomycosis. However, these agents differ markedly in their potential to cause clinically signifi
Newer antifungal agents for invasive fun
โ
Thomas R. Rogers; Susanna Frost
๐
Article
๐
2009
๐
John Wiley and Sons
๐
English
โ 121 KB
Importance of identification of zygomyce
โ
A.M. Bal
๐
Article
๐
2006
๐
John Wiley and Sons
๐
English
โ 46 KB
The Newer Anticholinergic Agents *
โ
Zupko, Arthur G. ;Prokop, Leon D.
๐
Article
๐
1954
๐
Elsevier
โ 368 KB
The Newer Anticholinergic Agents
โ
Zupko, Arthur G ;Prokop, Leon D
๐
Article
๐
1954
๐
Elsevier
โ 283 KB